{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:09:12Z","timestamp":1792782552431,"version":"4.5.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,12,2]],"date-time":"2016-12-02T00:00:00Z","timestamp":1480636800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,12,2]],"date-time":"2016-12-02T00:00:00Z","timestamp":1480636800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["2P40RR017447-07"],"award-info":[{"award-number":["2P40RR017447-07"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Theocorp Holding Co"},{"name":"Institute for Regenerative Medicine Program Funds"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1007\/s00223-016-0215-6","type":"journal-article","created":{"date-parts":[[2016,12,2]],"date-time":"2016-12-02T03:17:58Z","timestamp":1480648678000},"page":"298-310","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Theobromine Upregulates Osteogenesis by Human Mesenchymal Stem Cells In Vitro and Accelerates Bone Development in Rats"],"prefix":"10.1007","volume":"100","author":[{"given":"Bret H.","family":"Clough","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joni","family":"Ylostalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Browder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eoin P.","family":"McNeill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Bartosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Ralph","family":"Rawls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuo","family":"Nakamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl A.","family":"Gregory","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,12,2]]},"reference":[{"key":"215_CR1","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/978-3-642-13443-2_7","volume":"200","author":"HJ Smit","year":"2011","unstructured":"Smit HJ (2011) Theobromine and the pharmacology of cocoa. Handb Exp Pharmacol 200:201\u2013234","journal-title":"Handb Exp Pharmacol"},{"key":"215_CR2","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/0278-6915(88)90073-7","volume":"26","author":"B Stavric","year":"1988","unstructured":"Stavric B (1988) Methylxanthines: toxicity to humans. 3. Theobromine, paraxanthine and the combined effects of methylxanthines. Food Chem Toxicol 26:725\u2013733","journal-title":"Food Chem Toxicol"},{"key":"215_CR3","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/1755-5922.12076","volume":"32","author":"S Champion","year":"2014","unstructured":"Champion S, Lapidus N, Cheri\u00e9 G, Spagnoli V, Oliary J, Solal AC (2014) Pentoxifylline in heart failure: a meta-analysis of clinical trials. Cardiovasc Ther 32:159\u2013162","journal-title":"Cardiovasc Ther"},{"key":"215_CR4","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/0162-0134(92)84057-T","volume":"48","author":"J Kaur","year":"1992","unstructured":"Kaur J, Sodhi GS (1992) Diuretic activity of organomercury (II) complexes of theophylline and theobromine. J Inorg Biochem 48:305\u2013310","journal-title":"J Inorg Biochem"},{"key":"215_CR5","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1161\/01.CIR.103.8.1083","volume":"103","author":"D Skudicky","year":"2001","unstructured":"Skudicky D, Bergemann A, Sliwa K, Candy G, Sareli P (2001) Beneficial effects of pentoxifylline in patients with idiopathic dilated cardiomyopathy treated with angiotensin-converting enzyme inhibitors and carvedilol: results of a randomized study. Circulation 103:1083\u20131088","journal-title":"Circulation"},{"key":"215_CR6","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/S1388-9842(02)00008-9","volume":"4","author":"K Sliwa","year":"2002","unstructured":"Sliwa K, Skudicky D, Candy G, Bergemann A, Hopley M, Sareli P (2002) The addition of pentoxifylline to conventional therapy improves outcome in patients with peripartum cardiomyopathy. Eur J Heart Fail 4:305\u2013309","journal-title":"Eur J Heart Fail"},{"key":"215_CR7","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1007\/s00228-012-1452-x","volume":"69","author":"Z Nasiri-Toosi","year":"2013","unstructured":"Nasiri-Toosi Z, Dashti-Khavidaki S, Khalili H, Lessan-Pezeshki M (2013) A review of the potential protective effects of pentoxifylline against drug-induced nephrotoxicity. Eur J Clin Pharmacol 69:1057\u20131073","journal-title":"Eur J Clin Pharmacol"},{"key":"215_CR8","doi-asserted-by":"publisher","first-page":"128","DOI":"10.18433\/J3BP4G","volume":"14","author":"S Badri","year":"2011","unstructured":"Badri S, Dashti-Khavidaki S, Lessan-Pezeshki M, Abdollahi M (2011) A review of the potential benefits of pentoxifylline in diabetic and non-diabetic proteinuria. J Pharm Pharm Sci 14:128\u2013137","journal-title":"J Pharm Pharm Sci"},{"key":"215_CR9","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1891\/0730-0832.24.4.45","volume":"24","author":"SG Bell","year":"2005","unstructured":"Bell SG (2005) Immunomodulation, part I: pentoxifylline. Neonatal Netw 24:45\u201348","journal-title":"Neonatal Netw"},{"key":"215_CR10","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1097\/00007890-200003270-00014","volume":"69","author":"C Noel","year":"2000","unstructured":"Noel C, Copin MC, Hazzan M, Labalette M, Susen S, Lelievre G, Dessaint JP (2000) Immunomodulatory effect of pentoxifylline during human allograft rejection: involvement of tumor necrosis factor-alpha and adhesion molecules. Transplantation 69:1102\u20131107","journal-title":"Transplantation"},{"key":"215_CR11","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3109\/08923970903183557","volume":"32","author":"TW Costantini","year":"2010","unstructured":"Costantini TW, Deree J, Peterson CY, Putnam JG, Woon T, Loomis WH, Bansal V, Coimbra R (2010) Pentoxifylline modulates p47phox activation and downregulates neutrophil oxidative burst through PKA-dependent and -independent mechanisms. Immunopharmacol Immunotoxicol 32:82\u201391","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"215_CR12","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/0165-2478(93)90022-T","volume":"37","author":"K Rieneck","year":"1993","unstructured":"Rieneck K, Diamant M, Haahr PM, Sch\u00f6nharting M, Bendtzen K (1993) In vitro immunomodulatory effects of pentoxifylline. Immunol Lett 37:131\u2013138","journal-title":"Immunol Lett"},{"key":"215_CR13","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1111\/j.1365-2621.1980.tb02603.x","volume":"45","author":"BL Zoumas","year":"1980","unstructured":"Zoumas BL, Kreiser WR, Martin RA (1980) Theobromine and caffeine content in chocolate products. J Food Sci 45:314","journal-title":"J Food Sci"},{"key":"215_CR14","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1111\/j.1365-2621.1984.tb13737.x","volume":"49","author":"WJ Craig","year":"1984","unstructured":"Craig WJ, Nguyen TT (1984) Caffeine and theobromine levels in cocoa and cocoa products. J Food Sci 49:302","journal-title":"J Food Sci"},{"key":"215_CR15","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/0041-008X(79)90285-0","volume":"49","author":"SM Tarka Jr","year":"1979","unstructured":"Tarka SM Jr, Zoumas BL, Gans JH (1979) Short-term effects of graded levels of theobromine in laboratory rodents. Toxicol Appl Pharmacol 49:127\u2013149","journal-title":"Toxicol Appl Pharmacol"},{"key":"215_CR16","unstructured":"Nakamoto T, Simmons WB, Falster AU (1999) Products of apatite-forming-systems. US Patent US5919426A"},{"key":"215_CR17","unstructured":"Nakamoto T, Simmons WB, Falster AU (2001) Apatite-forming-systems: Methods and products. US Patent US 6183711"},{"issue":"1","key":"215_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/jcr.2015.0023","volume":"6","author":"T Nakamoto","year":"2016","unstructured":"Nakamoto T, Falster AU, Simmons WB (2016) Theobromine: a safe and effective alternative for fluoride in dentifrices. J Caffeine Res 6(1):1\u20139","journal-title":"J Caffeine Res"},{"key":"215_CR19","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1159\/000348589","volume":"47","author":"BT Amaechi","year":"2013","unstructured":"Amaechi BT, Porteous N, Ramalingam K, Mensinkai PK, Ccahuana Vasquez RA, Sadeghpour A, Nakamoto T (2013) Remineralization of artificial enamel lesions by theobromine. Caries Res 47:399\u2013405","journal-title":"Caries Res"},{"key":"215_CR20","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1017\/S0029665100000070","volume":"59","author":"R Namgung","year":"2000","unstructured":"Namgung R, Tsang RC (2000) Factors affecting newborn bone mineral content: in utero effects on newborn bone mineralization. Proc Nutr Soc 59:55\u201363","journal-title":"Proc Nutr Soc"},{"key":"215_CR21","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1111\/j.1530-0277.1998.tb03913.x","volume":"22","author":"BF Habbick","year":"1998","unstructured":"Habbick BF, Blakley PM, Houston CS, Snyder RE, Senthilselvan A, Nanson JL (1998) Bone age and growth in fetal alcohol syndrome. Alcohol Clin Exp Res 22:1312\u20131316","journal-title":"Alcohol Clin Exp Res"},{"key":"215_CR22","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1359\/jbmr.2001.16.9.1694","volume":"16","author":"K Godfrey","year":"2001","unstructured":"Godfrey K, Walker-Bone K, Robinson S, Taylor P, Shore S, Wheeler T, Cooper C (2001) Neonatal bone mass: influence of parental birthweight, maternal smoking, body composition, and activity during pregnancy. J Bone Miner Res 16:1694\u20131703","journal-title":"J Bone Miner Res"},{"key":"215_CR23","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1007\/s11914-014-0210-7","volume":"12","author":"EM Curtis","year":"2014","unstructured":"Curtis EM, Moon RJ, Dennison EM, Harvey NC (2014) Prenatal calcium and vitamin D intake, and bone mass in later life. Curr Osteoporos Rep 12:194\u2013204","journal-title":"Curr Osteoporos Rep"},{"key":"215_CR24","doi-asserted-by":"publisher","first-page":"R53","DOI":"10.1530\/EJE-14-0424","volume":"172","author":"L Sanz-Salvador","year":"2015","unstructured":"Sanz-Salvador L, Garcia-Perez MA, Tarin JJ, Cano A (2015) Bone metabolic changes during pregnancy: a period of vulnerability to osteoporosis and fracture. Eur J Endocrinol 172:R53\u2013R65","journal-title":"Eur J Endocrinol"},{"key":"215_CR25","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.arcped.2016.03.001","volume":"23","author":"M Gerin","year":"2016","unstructured":"Gerin M, Jambon G, Fouque-Aubert A, Raybaud C, Cochat P, Claris O, Bacchetta J (2016) Neonatal transient hypophosphatemic hypercalciuric rickets in dizygous twins: a role for maternal alendronate therapy before pregnancy or antireflux medications? Arch Pediatr 23:957\u2013962","journal-title":"Arch Pediatr"},{"key":"215_CR26","first-page":"1281","volume":"49","author":"AE French","year":"2003","unstructured":"French AE, Kaplan N, Lishner M, Koren G (2003) Taking bisphosphonates during pregnancy. Can Fam Physician 49:1281\u20131282","journal-title":"Can Fam Physician"},{"key":"215_CR27","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/0278-6915(87)90091-3","volume":"25","author":"HS Rosenkranz","year":"1987","unstructured":"Rosenkranz HS, Ennever FK (1987) Evaluation of the genotoxicity of theobromine and caffeine. Food Chem Toxicol 25:247\u2013251","journal-title":"Food Chem Toxicol"},{"key":"215_CR28","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/0378-4274(84)90167-X","volume":"20","author":"CA Shively","year":"1984","unstructured":"Shively CA, White DM, Blauch JL, Tarka SM Jr (1984) Dominant lethal testing of theobromine in rats. Toxicol Lett 20:325\u2013329","journal-title":"Toxicol Lett"},{"key":"215_CR29","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1002\/cpt1978233296","volume":"23","author":"DD Drouillard","year":"1978","unstructured":"Drouillard DD, Vesell ES, Dvorchik BH (1978) Studies on theobromine disposition in normal subjects. Alterations induced by dietary abstention from or exposure to methylxanthines. Clin Pharmacol Ther 23:296\u2013302","journal-title":"Clin Pharmacol Ther"},{"key":"215_CR30","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/clpt.1985.65","volume":"37","author":"CA Shively","year":"1985","unstructured":"Shively CA, Tarka SM Jr, Arnaud MJ, Dvorchik BH, Passananti GT, Vesell ES (1985) High levels of methylxanthines in chocolate do not alter theobromine disposition. Clin Pharmacol Ther 37:415\u2013424","journal-title":"Clin Pharmacol Ther"},{"key":"215_CR31","first-page":"208","volume-title":"Culture of human stem cells","author":"CA Gregory","year":"2007","unstructured":"Gregory CA, Prockop DJ (2007) Fundementals of culture and characterization of mesenchymal stem\/progenitor cells from bone marrow stroma. In: Freshney RI, Stacey GN, Auerbach JM (eds) Culture of human stem cells. Wiley-Liss, Hoboken, p 208"},{"key":"215_CR32","doi-asserted-by":"publisher","first-page":"132ra155","DOI":"10.1126\/scitranslmed.3003396","volume":"4","author":"S Zeitouni","year":"2012","unstructured":"Zeitouni S, Krause U, Clough BH, Halderman H, Falster A, Blalock DT, Chaput CD, Sampson HW, Gregory CA (2012) Human mesenchymal stem cell-derived matrices for enhanced osteoregeneration. Sci Transl Med 4:132ra155","journal-title":"Sci Transl Med"},{"key":"215_CR33","doi-asserted-by":"publisher","first-page":"P3","DOI":"10.1186\/gb-2003-4-5-p3","volume":"4","author":"G Dennis","year":"2003","unstructured":"Dennis G, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA (2003) DAVID: database for annotation, visualization, and integrated discovery. Genome Biol 4:P3","journal-title":"Genome Biol"},{"key":"215_CR34","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14653240600855905","volume":"8","author":"M Dominici","year":"2006","unstructured":"Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8:315\u2013317","journal-title":"Cytotherapy"},{"key":"215_CR35","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/978-1-60761-999-4_17","volume":"698","author":"U Krause","year":"2011","unstructured":"Krause U, Seckinger A, Gregory CA (2011) Assays of osteogenic differentiation by cultured human mesenchymal stem cells. Methods Mol Biol 698:215\u2013230","journal-title":"Methods Mol Biol"},{"key":"215_CR36","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1177\/10454411920030010601","volume":"3","author":"MS Johnsson","year":"1992","unstructured":"Johnsson MS, Nancollas GH (1992) The role of brushite and octacalcium phosphate in apatite formation. Crit Rev Oral Biol Med 3:61\u201382","journal-title":"Crit Rev Oral Biol Med"},{"key":"215_CR37","doi-asserted-by":"publisher","first-page":"33132","DOI":"10.1074\/jbc.M500608200","volume":"280","author":"T Gaur","year":"2005","unstructured":"Gaur T, Lengner CJ, Hovhannisyan H, Bhat RA, Bodine PV, Komm BS, Javed A, van Wijnen AJ, Stein JL, Stein GS, Lian JB (2005) Canonical WNT signaling promotes osteogenesis by directly stimulating Runx2 gene expression. J Biol Chem 280:33132\u201333140","journal-title":"J Biol Chem"},{"key":"215_CR38","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/jcp.20656","volume":"208","author":"YF Dong","year":"2006","unstructured":"Dong YF, Soung DY, Schwarz EM, O\u2019Keefe RJ, Drissi H (2006) Wnt induction of chondrocyte hypertrophy through the Runx2 transcription factor. J Cell Physiol 208:77\u201386","journal-title":"J Cell Physiol"},{"key":"215_CR39","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.bone.2012.09.029","volume":"52","author":"R Zhang","year":"2013","unstructured":"Zhang R, Oyajobi BO, Harris SE, Chen D, Tsao C, Deng HW, Zhao M (2013) Wnt\/\u03b2-catenin signaling activates bone morphogenetic protein 2 expression in osteoblasts. Bone 52:145\u2013156","journal-title":"Bone"},{"key":"215_CR40","doi-asserted-by":"publisher","first-page":"e837","DOI":"10.1371\/journal.pone.0000837","volume":"2","author":"F Kugimiya","year":"2007","unstructured":"Kugimiya F, Kawaguchi H, Ohba S, Kawamura N, Hirata M, Chikuda H, Azuma Y, Woodgett JR, Nakamura K, Chung UI (2007) GSK-3beta controls osteogenesis through regulating Runx2 activity. PLoS ONE 2:e837","journal-title":"PLoS ONE"},{"key":"215_CR41","first-page":"2688","volume":"123","author":"Z Wang","year":"2010","unstructured":"Wang Z, Zhang JN, Hu XF, Chen XL, Wang XR, Zhao TT, Peng MJ, Zou P (2010) Effects of pentoxifylline on Wnt\/beta-catenin signaling in mice chronically exposed to cigarette smoke. Chin Med J 123:2688\u20132694","journal-title":"Chin Med J"},{"key":"215_CR42","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.1039\/C5FO00397K","volume":"6","author":"YJ Jang","year":"2015","unstructured":"Jang YJ, Koo HJ, Sohn EH, Kang SC, Rhee DK, Pyo S (2015) Theobromine inhibits differentiation of 3T3-L1 cells during the early stage of adipogenesis via AMPK and MAPK signaling pathways. Food Funct 6:2365\u20132374","journal-title":"Food Funct"},{"key":"215_CR43","doi-asserted-by":"publisher","first-page":"4147","DOI":"10.1073\/pnas.0914360107","volume":"107","author":"U Krause","year":"2010","unstructured":"Krause U, Harris S, Green A, Ylostalo J, Zeitouni S, Lee N, Gregory CA (2010) Pharmaceutical modulation of canonical Wnt signaling in multipotent stromal cells for improved osteoinductive therapy. Proc Natl Acad Sci USA 107:4147\u20134152","journal-title":"Proc Natl Acad Sci USA"},{"key":"215_CR44","doi-asserted-by":"publisher","first-page":"30998","DOI":"10.1074\/jbc.M204527200","volume":"277","author":"CN Bennett","year":"2002","unstructured":"Bennett CN, Ross SE, Longo KA, Bajnok L, Hemati N, Johnson KW, Harrison SD, MacDougald OA (2002) Regulation of Wnt signaling during adipogenesis. J Biol Chem 277:30998\u201331004","journal-title":"J Biol Chem"},{"issue":"Suppl 1","key":"215_CR45","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1038\/sj.ijo.0802907","volume":"29","author":"SR Farmer","year":"2005","unstructured":"Farmer SR (2005) Regulation of PPARgamma activity during adipogenesis. Int J Obes (Lond) 29(Suppl 1):S13\u2013S16","journal-title":"Int J Obes (Lond)"},{"key":"215_CR46","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1042\/bj20030426","volume":"376","author":"M Moldes","year":"2003","unstructured":"Moldes M, Zuo Y, Morrison RF, Silva D, Park BH, Liu J, Farmer SR (2003) Peroxisome-proliferator-activated receptor gamma suppresses Wnt\/beta-catenin signalling during adipogenesis. Biochem J 376:607\u2013613","journal-title":"Biochem J"},{"issue":"3","key":"215_CR47","doi-asserted-by":"publisher","first-page":"247","DOI":"10.2174\/1574888X10666150723145707","volume":"11","author":"C Xu","year":"2016","unstructured":"Xu C, Wang J, Zhu T, Shen Y, Tang X, Fang L, Xu Y (2016) Cross-talking between PPAR and WNT signaling and its regulation in mesenchymal stem cell differentiation. Curr Stem Cell Res Ther 11(3):247\u2013254","journal-title":"Curr Stem Cell Res Ther"},{"key":"215_CR48","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/nrrheum.2009.137","volume":"5","author":"I Takada","year":"2009","unstructured":"Takada I, Kouzmenko AP, Kato S (2009) Wnt and PPARgamma signaling in osteoblastogenesis and adipogenesis. Nat Rev Rheumatol 5:442\u2013447","journal-title":"Nat Rev Rheumatol"},{"key":"215_CR49","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/0278-6915(86)90201-2","volume":"24","author":"SM Tarka Jr","year":"1986","unstructured":"Tarka SM Jr, Applebaum RS, Borzelleca JF (1986) Evaluation of the perinatal, postnatal and teratogenic effects of cocoa powder and theobromine in Sprague-Dawley\/CD rats. Food Chem Toxicol 24:375\u2013382","journal-title":"Food Chem Toxicol"},{"key":"215_CR50","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1271\/bbb.70.1134","volume":"70","author":"H Inoue","year":"2006","unstructured":"Inoue H, Kobayashi-Hattori K, Horiuchi Y, Oishi Y, Arai S, Takita T (2006) Regulation of the body fat percentage in developmental-stage rats by methylxanthine derivatives in a high-fat diet. Biosci Biotechnol Biochem 70:1134\u20131139","journal-title":"Biosci Biotechnol Biochem"},{"key":"215_CR51","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1007\/BF01622201","volume":"4","author":"AM Parfitt","year":"1994","unstructured":"Parfitt AM (1994) The two faces of growth: benefits and risks to bone integrity. Osteoporos Int 4:382\u2013398","journal-title":"Osteoporos Int"},{"key":"215_CR52","doi-asserted-by":"publisher","first-page":"574S","DOI":"10.1080\/07315724.2005.10719506","volume":"24","author":"RP Heaney","year":"2005","unstructured":"Heaney RP, Weaver CM (2005) Newer perspectives on calcium nutrition and bone quality. J Am Coll Nutr 24:574S\u2013581S","journal-title":"J Am Coll Nutr"},{"key":"215_CR53","doi-asserted-by":"publisher","first-page":"3597","DOI":"10.1073\/pnas.95.7.3597","volume":"95","author":"H Yasuda","year":"1998","unstructured":"Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S, Tomoyasu A, Yano K, Goto M, Murakami A, Tsuda E, Morinaga T, Higashio K, Udagawa N, Takahashi N, Suda T (1998) Osteoclast differentiation factor is a ligand for osteoprotegerin\/osteoclastogenesis-inhibitory factor and is identical to TRANCE\/RANKL. Proc Natl Acad Sci USA 95:3597\u20133602","journal-title":"Proc Natl Acad Sci USA"},{"key":"215_CR54","first-page":"139","volume":"53","author":"S Seminara","year":"2000","unstructured":"Seminara S, Rapisardi G, La Cauza F, Mattei P, Donzelli G (2000) Catch-up growth in short-at-birth NICU graduates. Horm Res 53:139\u2013143","journal-title":"Horm Res"},{"key":"215_CR55","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.ecl.2016.01.008","volume":"45","author":"M van der Steen","year":"2016","unstructured":"van der Steen M, Hokken-Koelega AC (2016) Growth and metabolism in children born small for gestational age. Endocrinol Metab Clin North Am 45:283\u2013294","journal-title":"Endocrinol Metab Clin North Am"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-016-0215-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00223-016-0215-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-016-0215-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T01:30:19Z","timestamp":1589679019000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00223-016-0215-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,2]]},"references-count":55,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["215"],"URL":"https:\/\/doi.org\/10.1007\/s00223-016-0215-6","relation":{},"ISSN":["0171-967X","1432-0827"],"issn-type":[{"value":"0171-967X","type":"print"},{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,2]]},"assertion":[{"value":"30 September 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"TN is co-founder of Theocorp Holding Co. CAG and HRR are members of the Scientific Advisory Board of Theocorp Holding Co. BHC, JY, EB, EPM and TJB state no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Animal studies were performed in accordance with an ethical animal use protocol approved by the Texas A&M Institutional Animal Care and Use Committee. Human mesenchymal stem cells were acquired from the Texas A&M Health Science Center Institute for Regenerative Medicine in accordance with a Baylor Scott and White Hospital and Texas A&M Health Science Center Institutional Review Board approved protocol for ethical acquisition of human tissue samples.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights and informed consent"}}]}}